Cite
Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGEN TM): Early Clinical Results.
MLA
Ris, Frederic, et al. “Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGEN TM): Early Clinical Results.” Cancers, vol. 13, no. 16, Aug. 2021, p. 4104. EBSCOhost, https://doi.org/10.3390/cancers13164104.
APA
Ris, F., Hellan, M., Douissard, J., Nieva, J. J., Triponez, F., Woo, Y., Geller, D., Buchs, N. C., Buehler, L., Moenig, S., Iselin, C. E., Karenovics, W., Petignat, P., Lam, G. T., Undurraga Malinervo, M., Tuttle, R., Ouellette, J., Bose, D., Ismail, N., & Toso, C. (2021). Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGEN TM): Early Clinical Results. Cancers, 13(16), 4104. https://doi.org/10.3390/cancers13164104
Chicago
Ris, Frederic, Minia Hellan, Jonathan Douissard, Jorge J. Nieva, Frederic Triponez, Yanghee Woo, David Geller, et al. 2021. “Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGEN TM): Early Clinical Results.” Cancers 13 (16): 4104. doi:10.3390/cancers13164104.